University of Tuebingen, Internal medicine IV
Tübingen, 72074, Germany
NCT Number: NCT01847456
The researchers will investigate if brain insulin action influences peripheral insulin sensitivity in healthy humans.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Tübingen, 72074, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 45 minutes to 120 minutes post nasal spray
We will measure insulin sensitivity by hyperinsulinemic euglycemic clamp before and after nasal spray application. We will compare the post-spray insulin sensitivity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare insulin sensitivity before and after nasal insulin application.
Time frame: 45 to 120 minutes post spray
Activity of the autonomous nervous system will be estimated by heart rate variability in ECG. We will compare the post-spray autonomous nervous system activity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare autonomous nervous system activity before and after nasal insulin application.
Looking for future studies?
Notify MeUniversity Hospital Tuebingen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05337098
Continuous Glucose Monitoring, Glucose Metabolism Disorders
Blacksburg, Virginia, United States
View Trial DetailsNCT05558488
Acid-Base Imbalance, Acidosis
Poznan, Greater Poland Voivodeship, Poland
View Trial DetailsNCT05649176
Apathy, Glucose Metabolism Disorders
Baton Rouge, Louisiana, United States
View Trial DetailsNCT06216665
Glucose Metabolism Disorders, Hyperinsulinism
Baton Rouge, Louisiana, United States
View Trial Details